Zobrazeno 1 - 10
of 190
pro vyhledávání: '"MESH : Vaccination"'
Autor:
Chloé Dimeglio, Pauline Trémeaux, Fabrice Herin, Isabelle Da-Silva, Marion Porcheron, Guillaume Martin-Blondel, Caroline Gernigon, Sabine Chapuy-Regaud, Hélène Villars, Jacques Izopet
Publikováno v:
Journal of Infection
Journal of Infection, 2022, 85 (6), pp.702-769. ⟨10.1016/j.jinf.2022.08.040⟩
Journal of Infection, 2022, 85 (6), pp.702-769. ⟨10.1016/j.jinf.2022.08.040⟩
International audience; Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 is particularly severe in older individuals because of an impaired immune response.1 The vaccines presently available are less efficacious in older individuals, beca
Autor:
Leonardo Martinez, Olivia Cords, Qiao Liu, Carlos Acuna-Villaorduna, Maryline Bonnet, Greg J Fox, Anna Cristina C Carvalho, Pei-Chun Chan, Julio Croda, Philip C Hill, Elisa Lopez-Varela, Simon Donkor, Katherine Fielding, Stephen M Graham, Marcos A Espinal, Beate Kampmann, Arthur Reingold, Helena Huerga, Julian A Villalba, Louis Grandjean, Giovanni Sotgiu, Uzochukwu Egere, Sarman Singh, Limei Zhu, Christian Lienhardt, Justin T Denholm, James A Seddon, Christopher C Whalen, Alberto L García-Basteiro, Rina Triasih, Cheng Chen, Jitendra Singh, Li-Min Huang, Surendra Sharma, Djohar Hannoun, Helena del Corral, Anna M Mandalakas, LaShaunda L Malone, Du-Lin Ling, Afrânio Kritski, Catherine M Stein, Richa Vashishtha, Fadila Boulahbal, Chi-Tai Fang, W Henry Boom, Eduardo Martins Netto, Antonio Carlos Lemos, Anneke C Hesseling, Alexander Kay, Edward C Jones-López, C Robert Horsburgh, Christoph Lange, Jason R Andrews
Publikováno v:
The Lancet global health
The Lancet global health, 2022, 10 (9), pp.e1307-e1316. ⟨10.1016/S2214-109X(22)00283-2⟩
The Lancet global health, 2022, 10 (9), pp.e1307-e1316. ⟨10.1016/S2214-109X(22)00283-2⟩
BACKGROUND: BCG vaccines are given to more than 100 million children every year, but there is considerable debate regarding the effectiveness of BCG vaccination in preventing tuberculosis and death, particularly among older children and adults. We th
Autor:
Minto'O, Steeve, Kamgaing, E Kuissi, Bisvigou, Ulrick, Loembe, F, Nze, D Zoua, Ngoungou, Edgard Brice, Ategbo, Simon
Publikováno v:
Indian Pediatrics
Indian Pediatrics, Springer Verlag, 2022, 59 (4), pp.290-292
Indian Pediatrics, Springer Verlag, 2022, 59 (4), pp.290-292
International audience; Objective: We aimed to assess hepatitis B vaccination coverage (vaccine coverage) among preschool children in Libreville, Gabon, and determine associated factors.Methods: A cross-sectional study was done evaluating hepatitis B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cb6c237f2b7ec61e6e176b2328daeb83
https://hal-unilim.archives-ouvertes.fr/hal-03692224
https://hal-unilim.archives-ouvertes.fr/hal-03692224
Autor:
Gaelle, Noel, Laurence, Borand, Chanthy, Leng, Chanthy, Keang, Chhunly, Botr, Bunnet, Dim, Alexandra, Kerleguer, Yik S, Peng, Navin, Sreng, Vichit, Ork, Mohand, Ait-Ahmed, Nicole, Guiso, Fabien, Taieb
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss, Pp 134-139 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Elsevier, 2021, 106, pp.134-139. ⟨10.1016/j.ijid.2021.03.054⟩
International Journal of Infectious Diseases, 2021, 106, pp.134-139. ⟨10.1016/j.ijid.2021.03.054⟩
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Elsevier, 2021, 106, pp.134-139. ⟨10.1016/j.ijid.2021.03.054⟩
International Journal of Infectious Diseases, 2021, 106, pp.134-139. ⟨10.1016/j.ijid.2021.03.054⟩
International audience; Background: The Cambodia pertussis immunization schedule includes three doses given at age 6, 10 and 14 weeks using a whole-pertussis vaccine. No booster doses are included. Pertussis biological diagnosis is unavailable in Cam
Publikováno v:
Vaccine
Vaccine, Elsevier, 2021, 39 (11), pp.1661-1666. ⟨10.1016/j.vaccine.2019.10.079⟩
Vaccine, Elsevier, 2021, 39 (11), pp.1661-1666. ⟨10.1016/j.vaccine.2019.10.079⟩
International audience; BackgroundAn oral vaccine is a potential tool to tackle the reservoir of Mycobacterium bovis in European badgers (Meles meles), which contributes to tuberculosis of cattle in the British Isles. Inferences about vaccine protect
Autor:
Laura Garcia, Tom Woudenberg, Jason Rosado, Adam H. Dyer, Françoise Donnadieu, Delphine Planas, Timothée Bruel, Olivier Schwartz, Thierry Prazuck, Aurélie Velay, Samira Fafi-Kremer, Isabella Batten, Conor Reddy, Emma Connolly, Matt McElheron, Sean P. Kennelly, Nollaig M. Bourke, Michael T. White, Stéphane Pelleau
Publikováno v:
Viruses; Volume 14; Issue 7; Pages: 1491
Viruses
Viruses, 2022, Special Issue SARS-CoV-2 Research in France, 14 (7), pp.1491. ⟨10.3390/v14071491⟩
Viruses
Viruses, 2022, Special Issue SARS-CoV-2 Research in France, 14 (7), pp.1491. ⟨10.3390/v14071491⟩
International audience; Serological assays capable of measuring antibody responses induced by previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been critical tools in the response to the COVID-19 pandemic. In t
Autor:
Anne-Laure Couderc, Laetitia Ninove, Emilie Nouguerède, Dominique Rey, Marina Rebroin, Aurélie Daumas, Pascale Tomasini, Laurent Greillier, Sebastien Salas, Florence Duffaud, Laetitia Dahan, Muriel Duluc, Marie-Eve Garcia, Johan Pluvy, Solène Chaléat, Laure Farnault, Geoffroy Venton, Toscane Fourié, Elif Nurtop, Xavier de Lamballerie, Patrick Villani, Remi Charrel, Florian Correard
Publikováno v:
Journal of Geriatric Oncology
Journal of Geriatric Oncology, 2022, 13 (6), pp.850-855. ⟨10.1016/j.jgo.2022.05.002⟩
Journal of Geriatric Oncology, 2022, 13 (6), pp.850-855. ⟨10.1016/j.jgo.2022.05.002⟩
The COVID-19 vaccination campaign began in December 2020, in France, and primarily targeted the oldest people. Our study aimed to determine the level of acceptance of vaccination in a population of older patients with cancer.From January 2021, we off
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32618f2501a921eb1762c226582a290d
https://hal.science/hal-03925558
https://hal.science/hal-03925558
Autor:
Kissling, Esther, Hooiveld, Mariëtte, Martínez-Baz, Iván, Mazagatos, Clara, William, Naoma, Vilcu, Ana-Maria, Kooijman, Marjolein N, Ilić, Maja, Domegan, Lisa, Machado, Ausenda, de Lusignan, Simon, Lazar, Mihaela, Meijer, Adam, Brytting, Mia, Casado, Itziar, Larrauri, Amparo, Murray, Josephine-L K, Behillil, Sylvie, de Gier, Brechje, Mlinarić, Ivan, O'Donnell, Joan, Rodrigues, Ana Paula, Tsang, Ruby, Timnea, Olivia, de Lange, Marit, Riess, Maximilian, Castilla, Jesús, Pozo Sanchez, Francisco, Hamilton, Mark, Falchi, Alessandra, Knol, Mirjam J, Kurečić Filipović, Sanja, Dunford, Linda, Guiomar, Raquel, Cogdale, Jade, Cherciu, Carmen, Jansen, Tessa, Enkirch, Theresa, Basile, Luca, Connell, Jeff, Gomez, Verónica, Sandonis-Martin, Virginia, Bacci, Sabrina, Rose, Angela Mc, Pastore Celentano, Lucia, Valenciano, Marta, I-MOVE-COVID-19, ECDC primary care study teams, Conde-San Román, Patricia, Casas Flecha, Inmaculada, Oliva Dominguez, Jesus Angel, Delgado-Sanz, Concepcion
Publikováno v:
Eurosurveillance
Eurosurveillance, 2022, 27 (21), ⟨10.2807/1560-7917.ES.2022.27.21.2101104⟩
Repisalud
Instituto de Salud Carlos III (ISCIII)
2022, ' Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe : multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 ', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 27, no. 21 . https://doi.org/10.2807/1560-7917.ES.2022.27.21.2101104
Eurosurveillance, 2022, 27 (21), ⟨10.2807/1560-7917.ES.2022.27.21.2101104⟩
Repisalud
Instituto de Salud Carlos III (ISCIII)
2022, ' Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe : multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 ', Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, vol. 27, no. 21 . https://doi.org/10.2807/1560-7917.ES.2022.27.21.2101104
Introduction In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. Methods Individuals with COVID-19 or a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc1844d2e879baa91cf237cc9f23a440
https://hal.science/hal-04000488
https://hal.science/hal-04000488
Autor:
Ioannis Sarrigeorgiou, Dimitra Moschandreou, Alexios Dimitriadis, Gerasimina Tsinti, Evangelia Sotiropoulou, Eleni Ntoukaki, Petros Eliadis, Marija Backovic, Stavroula Labropoulou, Nicolas Escriou, Abraham Pouliakis, Georgia Giannopoulou, Eleni Gaitanarou, Konstantinos Lazaridis, Andreas Mentis, Avgi Mamalaki, Elisavet Grouzi, Peggy Lymberi
Publikováno v:
PLoS ONE
PLoS ONE, 2022, 17 (11), pp.e0277827. ⟨10.1371/journal.pone.0277827⟩
PLoS ONE, 2022, 17 (11), pp.e0277827. ⟨10.1371/journal.pone.0277827⟩
International audience; Studies on the humoral response to homologous BNT162b2 mRNA-vaccination focus mainly on IgG antibody dynamics, while long-term IgA kinetics are understudied. Herein, kinetics of IgG and IgA levels against trimeric-Spike (S) an
Autor:
Boris Novakovic, Andreas Schlitzer, Giuseppe Matarese, Zahi A. Fayad, Willem J. M. Mulder, Henk Stunnenberg, Andrew R. DiNardo, Niels P. Riksen, Joachim L. Schultze, Christine Stabell Benn, Joseph C. Sun, Eva Kaufmann, Shabaana A. Khader, Michael H. Sieweke, Siroon Bekkering, Stephanie Fanucchi, Luis B. Barreiro, Maziar Divangahi, Mihai G. Netea, Reinout van Crevel, Jordi Ochando, Peter Aaby, Shruti Naik, Leo A. B. Joosten, Triantafyllos Chavakis, Musa M. Mhlanga, Eicke Latz, David L. Williams, Jos W. M. van der Meer, Luke A. J. O'Neill, Ramnik J. Xavier, Nigel Curtis, Robert W. Sauerwein, Kate L. Jeffrey, Edward R. Sherwood, Elaine Fuchs, Sebastian Weis, Nargis Khan, Melanie Hamon, Raphael Duivenwoorden, Keiko Ozato, Simone J.C.F.M. Moorlag, Jorge Domínguez-Andrés, Frank L. van de Veerdonk
Publikováno v:
Nature Immunology, 22(1), 2-6. Nature Publishing Group
Nat Immunol
Nature Immunology
Nature Immunology, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature Immunology, 22, 2-6
Nature Immunology, 22, 1, pp. 2-6
Divangahi, M, Aaby, P, Khader, S A, Barreiro, L B, Bekkering, S, Chavakis, T, van Crevel, R, Curtis, N, DiNardo, A R, Dominguez-Andres, J, Duivenwoorden, R, Fanucchi, S, Fayad, Z, Fuchs, E, Hamon, M, Jeffrey, K L, Khan, N, Joosten, L A B, Kaufmann, E, Latz, E, Matarese, G, van der Meer, J W M, Mhlanga, M, Moorlag, S J C F M, Mulder, W J M, Naik, S, Novakovic, B, O’Neill, L, Ochando, J, Ozato, K, Riksen, N P, Sauerwein, R, Sherwood, E R, Schlitzer, A, Schultze, J L, Sieweke, M H, Benn, C S, Stunnenberg, H, Sun, J, van de Veerdonk, F L, Weis, S, Williams, D L, Xavier, R & Netea, M G 2021, ' Trained immunity, tolerance, priming and differentiation : distinct immunological processes ', Nature Immunology, vol. 22, no. 1, pp. 2–6 . https://doi.org/10.1038/s41590-020-00845-6
Nature Immunology, Nature Publishing Group, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature immunology 22(1), 2-6 (2021). doi:10.1038/s41590-020-00845-6
Nature immunology, 22(1), 2-6. Nature Publishing Group
Nat Immunol
Nature Immunology
Nature Immunology, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature Immunology, 22, 2-6
Nature Immunology, 22, 1, pp. 2-6
Divangahi, M, Aaby, P, Khader, S A, Barreiro, L B, Bekkering, S, Chavakis, T, van Crevel, R, Curtis, N, DiNardo, A R, Dominguez-Andres, J, Duivenwoorden, R, Fanucchi, S, Fayad, Z, Fuchs, E, Hamon, M, Jeffrey, K L, Khan, N, Joosten, L A B, Kaufmann, E, Latz, E, Matarese, G, van der Meer, J W M, Mhlanga, M, Moorlag, S J C F M, Mulder, W J M, Naik, S, Novakovic, B, O’Neill, L, Ochando, J, Ozato, K, Riksen, N P, Sauerwein, R, Sherwood, E R, Schlitzer, A, Schultze, J L, Sieweke, M H, Benn, C S, Stunnenberg, H, Sun, J, van de Veerdonk, F L, Weis, S, Williams, D L, Xavier, R & Netea, M G 2021, ' Trained immunity, tolerance, priming and differentiation : distinct immunological processes ', Nature Immunology, vol. 22, no. 1, pp. 2–6 . https://doi.org/10.1038/s41590-020-00845-6
Nature Immunology, Nature Publishing Group, 2021, 22 (1), pp.2-6. ⟨10.1038/s41590-020-00845-6⟩
Nature immunology 22(1), 2-6 (2021). doi:10.1038/s41590-020-00845-6
Nature immunology, 22(1), 2-6. Nature Publishing Group
The similarities and differences between trained immunity and other immune processes are the subject of intense interrogation. Therefore, a consensus on the definition of trained immunity in both in vitro and in vivo settings, as well as in experimen